GlassScriptPhysician profile
Melissa M Go
NPI 1053305540
$4,665.69
in general payments reported to CMS, 2019-2025
30 companies · $696 in 2025
The $696 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $280 · 2021: $591 · 2022: $623 · 2023: $1,172 · 2024: $710 · 2025: $696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,520 · Education: $58.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,519.80 |
| Education | $58.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $486.63 | 2019-2025 | Farxiga, Lokelma, Flumist Quadrivalent |
| Otsuka America Pharmaceutical, INC. | $478.22 | 2019-2024 | Jynarque |
| Opko Pharmaceuticals, LLC | $351.50 | 2020-2024 | Rayaldee |
| Akebia Therapeutics INC | $344.81 | 2019-2025 | Vafseo, Auryxia |
| Bayer Healthcare Pharmaceuticals INC. | $328.22 | 2021-2025 | |
| Amgen INC. | $307.52 | 2019-2025 | Tavneos, Krystexxa |
| Travere Therapeutics, INC. | $230.43 | 2022-2025 | |
| Horizon Therapeutics Plc | $207.26 | 2021-2023 | Krystexxa |
| Vifor Pharma, INC. | $199.13 | 2019-2023 | Veltassa, Korsuva |
| Daiichi Sankyo INC. | $153.44 | 2019-2024 | Injectafer |
| Glaxosmithkline, LLC. | $148.35 | 2021-2024 | Benlysta, Jesduvroq |
| Mallinckrodt Hospital Products INC. | $139.95 | 2021-2024 | Terlivaz |
| Vantive US Healthcare LLC | $128.34 | 2025 | |
| Aurinia Pharma U.S., INC. | $127.20 | 2021-2024 | Lupkynis |
| Baxter Healthcare | $123.64 | 2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $113.38 | 2019-2024 | Jynarque |
| Calliditas Therapeutics US INC. | $97.97 | 2022-2025 | Tarpeyo |
| Ani Pharmaceuticals, INC. | $95.62 | 2022-2024 | Purified Cortrophin Gel |
| Genzyme Corporation | $78.98 | 2019 | |
| Alexion Pharmaceuticals, INC. | $74.41 | 2019-2023 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.15 | 2023-2025 | Jardiance |
| Ardelyx, INC. | $59.39 | 2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $51.73 | 2022-2023 | Livtencity |
| Kyowa Kirin, INC. | $51.13 | 2023 | Crysvita |
| Novo Nordisk INC | $47.51 | 2023-2024 | Ozempic |
| Novartis Pharmaceuticals Corporation | $46.82 | 2020-2024 | |
| Lilly USA, LLC | $43.67 | 2024-2025 | Jardiance |
| Mallinckrodt Enterprises LLC | $32.59 | 2019 | |
| Scpharmaceuticals INC. | $28.51 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $19.19 | 2024 | Crysvita |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Go listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.